Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Biotech ETF (BBH)

115.27
Delayed Data
As of Aug 26
 +0.80 / +0.70%
Today’s Change
93.10
Today|||52-Week Range
135.69
-9.20%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors  US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for VanEck Vectors Biotech ETF.

Performance

1 month+3.57% 3 years+13.46%
3 months+6.36% 5 years--
1 year-8.79% Since inception+28.93%
Data through 08/27/2016

Quote Details

Previous close$114.47
Open day’s range114.42 – 116.09
Net asset value (NAV)115.31 (08/26/2016)
Daily volume47,992
Average volume (3 months)77,576
Data as of 3:59pm ET, 08/26/2016

Peer Comparisonvs. Health ETFs

 BBHCategory
Performance 5-yr return--+15.32%
Expense Gross exp ratio0.40%0.47%
Risk 5 year sharpe ratio--1.12
Net assets$593.2M$1.2B
Average market cap$31.0B$31.2B
Average P/E18.818.7
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
VHT Vanguard Health Care Index Fund ETF Shar...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen14.21%
GILD Gilead Sciences11.79%
CELG Celgene11.08%
BIIB Biogen6.79%
REGN Regeneron Pharmaceuticals5.16%
BMRN Biomarin Pharmaceutical Inc5.03%
ILMN Illumina Inc4.87%
MDVN Medivation Inc4.53%
INCY Incyte Corp4.50%
VRTX Vertex Pharmaceuticals Inc4.36%

Partner Offers

Search for Jobs